7,467
Views
18
CrossRef citations to date
0
Altmetric
Review

Illicit drug use in pregnancy: effects and management

, &
Pages 179-192 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Laura Curran, Brittany Arthur-Jordan, Jessica Rice & Tony Tan. (2022) The risk of child removal by child protective services among pregnant women in medication-assisted treatment for opioid use disorder. Journal of Social Work Practice in the Addictions 22:2, pages 93-107.
Read now

Articles from other publishers (17)

So Bi Kim, Bethany White, Jillian Roberts & Carolyn A. Day. (2023) Substance use among pregnant women in NSW prisons. International Journal of Drug Policy 122, pages 104256.
Crossref
Miriam HarrisDavida M. SchiffKelley SaiaSerra MuftuKatherine R. StandishElisha M. Wachman. (2023) Academy of Breastfeeding Medicine Clinical Protocol #21: Breastfeeding in the Setting of Substance Use and Substance Use Disorder (Revised 2023). Breastfeeding Medicine 18:10, pages 715-733.
Crossref
Ali Kheradmand, Sahar Ashrafzadeh, Farzane Rouzegari, Samin Aliakbarian & Ali Naseh. (2023) Evaluation of Perinatal and Developmental Outcomes in Neonates with Abstinence Syndrome Admitted to NICU. International Journal of Mental Health Promotion 25:2, pages 265-274.
Crossref
Philip D. James. 2023. Alcohol Use: Assessment, Withdrawal Management, Treatment and Therapy. Alcohol Use: Assessment, Withdrawal Management, Treatment and Therapy 179 192 .
Humaira Khan & Luisa Cescutti-Butler. (2021) Enhancing undergraduate midwifery: using drug and alcohol baby simulators in education. British Journal of Midwifery 29:11, pages 620-627.
Crossref
Gemma Doleman, Sadie Geraghty & Annemarie DeLeo. (2019) Midwifery student's perceptions of caring for substance-using pregnant women. Nurse Education Today 76, pages 26-30.
Crossref
Hilary Davies-Kershaw, Irene Petersen, Irwin Nazareth & Fiona Stevenson. (2018) Factors influencing recording of drug misuse in primary care: a qualitative study of GPs in England. British Journal of General Practice 68:669, pages e234-e244.
Crossref
Verena E. Metz, Qiana L. Brown, Silvia S. Martins & Joseph J. Palamar. (2018) Characteristics of drug use among pregnant women in the United States: Opioid and non-opioid illegal drug use. Drug and Alcohol Dependence 183, pages 261-266.
Crossref
Benjamin S. Harris, Katherine C. Bishop, Hanna R. Kemeny, Jennifer S. Walker, Eleanor Rhee & Jeffrey A. Kuller. (2017) Risk Factors for Birth Defects. Obstetrical & Gynecological Survey 72:2, pages 123-135.
Crossref
Hilary Davies, Ruth Gilbert, Kathryn Johnson, Irene Petersen, Irwin Nazareth, Melissa O'Donnell, Astrid Guttmann & Arturo Gonzalez-Izquierdo. (2016) Neonatal drug withdrawal syndrome: cross-country comparison using hospital administrative data in England, the USA, Western Australia and Ontario, Canada. Archives of Disease in Childhood - Fetal and Neonatal Edition 101:1, pages 26-30.
Crossref
Angela O’Connor, Lucy Lewis, Renate McLaurin & Lisa Barnett. (2015) Maternal and neonatal outcomes of Hepatitis C positive women attending a midwifery led drug and alcohol service: A West Australian perspective. Midwifery 31:8, pages 793-797.
Crossref
Hilary R. Davies, Irwin Nazareth & Irene Petersen. (2015) Trends of People Using Drugs and Opioid Substitute Treatment Recorded in England and Wales General Practice (1994-2012). PLOS ONE 10:4, pages e0122626.
Crossref
Tammy Casper & Megan W. Arbour. (2013) Identification of the Pregnant Woman Who Is Using Drugs: Implications for Perinatal and Neonatal Care. Journal of Midwifery & Women's Health 58:6, pages 697-701.
Crossref
R. McLaurin & S. Geraghty. (2013) Placenta praevia, placental abruption and amphetamine use in pregnancy: A case study. Women and Birth 26:2, pages 138-142.
Crossref
M. V. Seeman. (2012) Clinical interventions for women with schizophrenia: pregnancy. Acta Psychiatrica Scandinavica 127:1, pages 12-22.
Crossref
Jayne C. Lucke & Wayne D. Hall. (2012) Under what conditions is it ethical to offer incentives to encourage drug‐using women to use long‐acting forms of contraception?. Addiction 107:6, pages 1036-1041.
Crossref
C. Damase-Michel, A. Daveluy, G. Miremont-Salamé, A. Boucher, F. Haramburu & T. Vial. 2012. Médicaments et Grossesse : Prescrire et évaluer le Risque. Médicaments et Grossesse : Prescrire et évaluer le Risque 257 265 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.